EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The microbiome–epigenome axis: Regulation of host genome function across development and disease

Qamar Abuhassan, Ali M Atoom, Subbulakshmi Ganesan, Rajashree Panigrahi, V Ramesh Kumar, Vipasha Sharma, Ashish Singh Chauhan, Gulandom Shodikulova

Cancer Treatment and Research Communications · 2026 · 48 · 101299

DOI: 10.1016/j.ctarc.2026.101299 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Qamar Abuhassan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Jordan, Amman, 11942, Jordan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Epigenesis, Genetic, Epigenome, Microbiota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome is increasingly recognized as a metabolically active regulator of host gene expression, translating environmental exposures-particularly diet-into epigenetic signals that shape development, immunity, metabolism, and disease susceptibility. This narrative review synthesizes current evidence for a microbiome-epigenome axis in which microbial metabolites and regulatory molecules modulate DNA methylation, histone modifications, non-coding RNA networks, RNA epitranscriptomic marks, and higher-order chromatin organization. Short-chain fatty acids act as histone deacetylase inhibitors, acyl-CoA donors, and regulators of histone acetyltransferase activity; microbially derived B vitamins influence one-carbon metabolism and S-adenosylmethionine availability; and bile acids, indoles, trimethylamine-N-oxide, and extracellular vesicle cargo signal through host metabolic, immune, and transcriptional pathways. Evidence from germ-free and recolonization models, genetic perturbation studies, in vitro systems, and human cohorts indicates that microbial signals exert particularly strong effects during developmental windows of heightened epigenetic plasticity, contributing to immune tolerance, trained innate immunity, and long-term metabolic programming. Dysbiosis may disrupt these regulatory circuits and promote inflammatory bowel disease, colorectal cancer, cardiometabolic and atherosclerotic disorders, and neurodevelopmental or neurodegenerative conditions. By integrating microbial metabolism with chromatin regulation, RNA-based control, and genome topology, this review highlights the microbiome as a dynamic epigenetic interface between environment and host physiology. Key challenges include establishing causality in humans, resolving temporal and tissue-specific mechanisms, and developing longitudinal multi-omics studies with functional validation. Targeted microbiome modulation may ultimately restore epigenetic homeostasis and support precision prevention and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeEpigenesis, GeneticEpigenomeMicrobiotaHumansAnimalsDNA Methylation

Stichwörter der Autor:innen

DNA methylationEpigenetic regulationGut microbiotaHistone modificationsShort-chain fatty acids

Autor:innen und Institutionen

  • Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Jordan, Amman, 11942, Jordan.
  • Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: Atoomali@proton.me.
  • Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
  • Department of Microbiology, IMS and SUM Hospital, Siksha 'O' Anusandhan, Bhubaneswar, Odisha 751003, India.
  • Department of Biotechnology, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
  • Department of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India.

Zitieren

APA

Abuhassan, Q., Atoom, A. M., Ganesan, S., Panigrahi, R., Kumar, V. R., Sharma, V., Chauhan, A. S., & Shodikulova, G. (2026). The microbiome–epigenome axis: Regulation of host genome function across development and disease. Cancer Treatment and Research Communications, 48, 101299. https://doi.org/10.1016/j.ctarc.2026.101299

Vancouver

Abuhassan Q, Atoom AM, Ganesan S, Panigrahi R, Kumar VR, Sharma V, et al. The microbiome–epigenome axis: Regulation of host genome function across development and disease. Cancer Treatment and Research Communications. 2026;48:101299. doi:10.1016/j.ctarc.2026.101299

BibTeX
@article{Abuhassan2026,
  author = {Abuhassan, Qamar and Atoom, Ali M and Ganesan, Subbulakshmi and Panigrahi, Rajashree and Kumar, V Ramesh and Sharma, Vipasha and Chauhan, Ashish Singh and Shodikulova, Gulandom},
  title = {The microbiome–epigenome axis: Regulation of host genome function across development and disease},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {48},
  pages = {101299},
  doi = {10.1016/j.ctarc.2026.101299}
}
Kostenlos starten →